Maucher Jenkins are pleased to run a webinar in collaboration with the Stevenage Bioscience Catalyst.

 

During the webinar we will provide advice on how to manage and maintain IP in these current challenging times, including options for obtaining funding and deferring costs. We will provide guidance on how to consider the legal situation when moving into new areas of manufacture and collaborating with others in the fight against the virus.

 

In addition, we will discuss the options available for protecting diagnostic and therapeutic methods to assist companies moving into the diagnostics industry to provide testing facilities. There will be time for questions and discussion at the end of the webinar.

 

Agenda

 

11:50 - 12:00 - Welcome from Maucher Jenkins

12:00-12:20 – Managing IP during COVID 19, including options available for obtaining funding and deferring costs

12:20-12:40 – Considerations when moving into new areas of manufacture, options available for protecting diagnostic and therapeutic methods

12:40 - 1:00 - Questions

 

Find more information following this link: Stevenage Bioscience Catalyst website